Hologic to Present New Data at ASCO 2025 on the Breast Cancer Index® Test’s Role in Personalized Care
Hologic
Assessment of over 2,800 patients highlights the profound impact of the BCI test in helping to predict the likelihood of extended endocrine therapy benefit for patients with HR+ breast cancer